Who Paid My Doc
Matthew Smyth
Neurological Surgery Saint Louis, MO Medical Doctor
NPI 1841218278 CMS profile 1070471
1 Childrens Pl Ste 4S20, Ste 4S20, Saint Louis, MO 63110
General payments
$44,454
Research payments
$300
Ownership & investment interest
$0
Research they led as principal investigator
$19,804
Through program year 2025, Matthew Smyth of Saint Louis, MO is reported in the CMS Open Payments database as having received $44,454 across 64 general payments and $300 in research payments paid to them. Separately, studies naming them as principal investigator received $19,804 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 85th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $400 | 1 | |
| 2024 | General | $12,555 | 14 | |
| 2023 | General | $9,908 | 14 | |
| 2022 | General | $16,207 | 25 | |
| 2022 | Research | $300 | 1 | |
| 2021 | General | $5,132 | 7 | |
| 2020 | General | $200 | 1 | |
| 2019 | General | $52 | 2 |
Beside peers
- Matthew Smyth
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to Matthew Smyth were reported at $400. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | Matthew Smyth | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $52 | $582 | $138–$3,006 | $163 |
| 2020 | $200 | $294 | $76–$2,174 | $114 |
| 2021 | $5,132 | $387 | $105–$2,432 | $132 |
| 2022 | $16,207 | $542 | $139–$2,989 | $149 |
| 2023 | $9,908 | $534 | $145–$2,697 | $160 |
| 2024 | $12,555 | $574 | $155–$3,046 | $164 |
| 2025 | $400 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
65 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in Missouri
Neill Wright
Neurological Surgery · Saint Louis, MO
Wilson Ray
Neurological Surgery · Saint Louis, MO
Carlos Bagley
Neurological Surgery · Kansas City, MO
Kaywan Gamadia
Neurological Surgery · Cape Girardeau, MO
Camilo Molina
Neurological Surgery · Saint Louis, MO
Paul Santiago
Neurological Surgery · Saint Louis, MO
Related records
Neurological Surgery in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.